Cargando…

Development of Praziquantel sulphonamide derivatives as antischistosomal drugs

The almost empty armamentarium to treat schistosomiasis, a neglected parasitic disorder caused by trematode flatworms of the genus Schistosoma, except Praziquantel (PZQ), urged to find new alternatives to fight this infection. Carbonic Anhydrase from Schistosoma mansoni (SmCA) is a possible new targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angeli, Andrea, Ferraroni, Marta, Carta, Fabrizio, Häberli, Cécile, Keiser, Jennifer, Costantino, Gabriele, Supuran, Claudiu T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154761/ https://www.ncbi.nlm.nih.gov/pubmed/35635137 http://dx.doi.org/10.1080/14756366.2022.2078970

Ejemplares similares

An Artemisinin Derivative of Praziquantel as an Orally Active Antischistosomal Agent
por: Dong, Lanlan, et al.
Publicado: (2014)

In Vitro Antileishmanial and Antischistosomal Activities of Anemonin Isolated from the Fresh Leaves of Ranunculus multifidus Forsk
por: Sirak, Betelhem, et al.
Publicado: (2021)

Selenocarbamates As a Prodrug‐Based Approach to Carbonic Anhydrase Inhibition
por: Angeli, Andrea, et al.
Publicado: (2022)

In vitro and in vivo antischistosomal activity of ferroquine derivatives
por: Keiser, Jennifer, et al.
Publicado: (2014)

Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents
por: Kasago, Freddy Mugisho, et al.
Publicado: (2023)

Inhibition of Schistosoma mansoni carbonic anhydrase by the antiparasitic drug clorsulon: X-ray crystallographic and in vitro studies
por: Ferraroni, Marta, et al.
Publicado: (2022)

Antischistosomal and anti-inflammatory activity of garlic and allicin compared with that of praziquantel in vivo
por: Metwally, Dina M., et al.
Publicado: (2018)

Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase
por: Urbanski, Linda J., et al.
Publicado: (2020)

Inhibition of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with sulphonamides
por: Urbański, Linda J., et al.
Publicado: (2020)

Amine- and Amino Acid-Based Compounds as Carbonic Anhydrase Activators
por: Angeli, Andrea, et al.
Publicado: (2021)

Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors
por: Güzel-Akdemir, Özlen, et al.
Publicado: (2018)

In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni
por: Mokbel, Kamal El-Din M., et al.
Publicado: (2020)

Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties
por: Sethi, Kalyan K., et al.
Publicado: (2021)

Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis
por: Keiser, Jennifer, et al.
Publicado: (2021)

Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice
por: Keiser, Jennifer, et al.
Publicado: (2009)

Crystal Structure of a Tetrameric Type II β-Carbonic Anhydrase from the Pathogenic Bacterium Burkholderia pseudomallei
por: Angeli, Andrea, et al.
Publicado: (2020)

Diversely N-substituted benzenesulfonamides dissimilarly bind to human carbonic anhydrases: crystallographic investigations of N-nitrosulfonamides
por: Angeli, Andrea, et al.
Publicado: (2023)

Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives
por: Shilkar, Deepak, et al.
Publicado: (2023)

Real-time and automated monitoring of antischistosomal drug activity profiles for screening of compound libraries
por: Ravaynia, Paolo S., et al.
Publicado: (2022)

Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica
por: Xu, Jing, et al.
Publicado: (2023)

Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
por: Vullo, Daniela, et al.
Publicado: (2017)

First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy
por: Angeli, Andrea, et al.
Publicado: (2023)

Crystal structure and chemical inhibition of essential schistosome host-interactive virulence factor carbonic anhydrase SmCA
por: Da’dara, Akram A., et al.
Publicado: (2019)

Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
por: Sharonova, Tatiana, et al.
Publicado: (2022)

Pyrazoline derivatives as promising novel antischistosomal agents
por: Morais, Cristiane S., et al.
Publicado: (2021)

Escherichia coli γ-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors
por: Del Prete, Sonia, et al.
Publicado: (2020)

A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection
por: Radwan, Amr, et al.
Publicado: (2019)

Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
por: Koyuncu, Ismail, et al.
Publicado: (2019)

Synthesis and human carbonic anhydrase I, II, VA, and XII inhibition with novel amino acid–sulphonamide conjugates
por: Küçükbay, Hasan, et al.
Publicado: (2020)

Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery
por: Mansoldo, Felipe Raposo Passos, et al.
Publicado: (2020)

Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978)
por: Wang, Chunkai, et al.
Publicado: (2016)

Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors
por: Rogato, Alessandra, et al.
Publicado: (2019)

Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine
por: Taylor, Alexander B., et al.
Publicado: (2015)

Antischistosomal Activity of the Terpene Nerolidol
por: Silva, Marcos P.N., et al.
Publicado: (2014)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

Antischistosomal, antionchocercal and antitrypanosomal potentials of some Ghanaian traditional medicines and their constituents
por: Twumasi, Emmanuella Bema, et al.
Publicado: (2020)

Antileishmanial activity of sulphonamide nanoemulsions targeting the β-carbonic anhydrase from Leishmania species
por: da Silva Cardoso, Verônica, et al.
Publicado: (2018)

Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosisβ-class enzyme Rv3273
por: Wani, Tanvi V., et al.
Publicado: (2018)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
por: Kovač, Jana, et al.
Publicado: (2017)

Studies on the Action of Synthetic Drugs on Simian Malaria: Sulphonamide Derivatives
por: Gupta, B. M. Das, et al.
Publicado: (1938)

Cannot write session to /tmp/vufind_sessions/sess_m7alvk2vuncvbv17dq0ak083bp